Table 1. Effect of RNS60 and NS on clinical symptoms of EAE.
Treatment | Incidence | Mean peak clinical score | Suppression of EAE | |
Incidence | Score | |||
EAE | 6/6 | 3.6 | ||
EAE+RNS60 (100 µl/mouse/d) | 5/5 | 2.0 | 0 | 44b |
EAE+RNS60 (200 µl/mouse/d) | 4/5 | 1.5 | 20 | 58a |
EAE+RNS60 (300 µl/mouse/d) | 2/5 | 0.8 | 60a | 78a |
EAE+NS (300 µl/mouse/d) | 5/5 | 3.5 | 0 | 3 |
EAE was induced in female SJL/J mice through adoptive transfer of MBP-primed T cells. From 0 dpt, mice were treated with different doses of RNS60 or NS via i.p. injection (dpt 1–8, alternate day; dpt 9–16, daily; dpt 17 onwards, alternate day). While a clinical score of 1 was considered as the incidence of EAE in mice, a clinical score of 0 was considered to be normal.
p<0.001,
p<0.01 vs EAE (control).